TIBET PHARMA(SH:600211) Zheng Quan Zhi Xing·2025-08-15 16:14Core Viewpoint - The company plans to distribute a cash dividend of 0.881 yuan per share (including tax) based on its net profit for the first half of 2025, amounting to a total cash distribution of approximately 283.96 million yuan, which represents 50.05% of the net profit attributable to the parent company [1][2]. Summary by Sections Profit Distribution Plan - The company reported a net profit attributable to the parent company of 567,323,117.52 yuan for the first half of 2025 (unaudited) [1]. - As of June 30, 2025, the company's total share capital was 322,319,196 shares, leading to a proposed total cash dividend distribution of 283,963,211.68 yuan (including tax) [1]. - The cash dividend distribution is based on the total share capital registered on the equity distribution record date, with adjustments to the per-share distribution amount if the total share capital changes before this date [2]. Decision-Making Process - The profit distribution plan was approved by the company's eighth board of directors with a unanimous vote of 9 in favor, 0 against, and 0 abstentions [2]. - The plan was also approved by the company's eighth supervisory board with a vote of 3 in favor, 0 against, and 0 abstentions [2]. - The annual shareholders' meeting in 2024 authorized the board to potentially increase the frequency of cash dividends based on actual conditions, without exceeding the net profit attributable to shareholders for the corresponding period [2].